Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

por Schnober, Dietmar, Hubatsch, Douglas A, Scherzer, Maria-Luise
Publicado 2015

Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension

por Schnober, Dietmar, Hofmann, Günter, Maier, Hubert, Scherzer, Maria-Luise, Ogundele, Abayomi B, Jasek, Mark C
Publicado 2010

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension

por Pfennigsdorf, Stefan, Ramez, Osman, von Kistowski, Gerrit, Mäder, Birgit, Eschstruth, Peter, Froböse, Michael, Thelen, Ulrich, Spraul, Christoph, Schnober, Dietmar, Cooper, Hazel, Laube, Thomas
Publicado 2012